Differential expression profiling of the synaptosome proteome in a rat model of antipsychotic resistance

Brain Research

Volumn 1295, Issue , 2009, Pages 170-178

  Ji, Baohu ^a,b   Zhang, Zhao ^a,b   Zhang, Ming ^a,b   Zhu, Hui ^a,b   Zhou, Kejun ^a,b   Yang, Jinglei ^a,b   Li, Yang ^a,b   Sun, Liya ^a,b   Feng, Guoyin ^c   Wang, Yujiong ^d   He, Lin ^a,b,e   Wan, Chunling ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c SHANGHAI MENTAL HEALTH CENTER   (China)

^d NINGXIA UNIVERSITY   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

Antipsychotic medication; G protein; Glycolysis Gluconeogenesis; Mitochondrial function; PLS DA; Schizophrenia; Synaptosome

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEOME; QUETIAPINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN SYNAPTOSOME; CELL FUNCTION; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENERGY YIELD; GLUCONEOGENESIS; GLYCOLYSIS; MALE; MITOCHONDRION; NONHUMAN; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SYNAPTIC POTENTIAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; CEREBRAL CORTEX; CHLORPROMAZINE; CLOZAPINE; DIBENZOTHIAZEPINES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PEPTIDE MAPPING; PROTEOME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SYNAPTOSOMES;

RATTUS;

EID: 70349236863     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.07.097     Document Type: Article

References (31)

1. Arai T., Miyoshi Y., Kim S.J., Akazawa K., Maruyama N., Taguchi T., Tamaki Y., and Noguchi S. Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers. Eur. J. Surg. Oncol. 34 (2008) 734-738
2. Ben Shachar D., Zuk R., Gazawi H., and Ljubuncic P. Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders. Biochem. Pharmacol. 67 (2004) 1965-1974
3. Bordelon J.R., Smith Y., Nairn A.C., Colbran R.J., Greengard P., and Muly E.C. Differential localization of protein phosphatase-1alpha, beta and gamma1 isoforms in primate prefrontal cortex. Cereb. Cortex 15 (2005) 1928-1937
4. Capurso G., Crnogorac-Jurcevic T., Milione M., Panzuto F., Campanini N., Dowen S.E., Di Florio A., Sette C., Bordi C., Lemoine N.R., and Delle F.G. Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas. Neuroendocrinology 81 (2005) 311-321
5. Chandra S., Fornai F., Kwon H.B., Yazdani U., Atasoy D., Liu X., Hammer R.E., Battaglia G., German D.C., Castillo P.E., and Sudhof T.C. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 14966-14971
6. Dawson S.J., and White L.A. Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin. J. Infect. 24 (1992) 317-320
7. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4 (2003) 3
8. Douglas R.M., Lai J.C., Bian S., Cummins L., Moczydlowski E., and Haddad G.G. The calcium-sensitive large-conductance potassium channel (BK/MAXI K) is present in the inner mitochondrial membrane of rat brain. Neuroscience 139 (2006) 1249-1261
9. Drew J.E., Padidar S., Horgan G., Duthie G.G., Russell W.R., Reid M., Duncan G., and Rucklidge G.J. Salicylate modulates oxidative stress in the rat colon: a proteomic approach. Biochem. Pharmacol. 72 (2006) 204-216
10. Eastwood S.L., Burnet P.W., and Harrison P.J. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 66 (1995) 309-319
11. Freedman R. Schizophrenia. N. Engl. J. Med. 349 (2003) 1738-1749
12. Gurkan C., Lapp H., Alory C., Su A.I., Hogenesch J.B., and Balch W.E. Large-scale profiling of Rab GTPase trafficking networks: the membrome. Mol. Biol. Cell 16 (2005) 3847-3864
13. Huang d.W., Sherman B.T., and Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4 (2009) 44-57
14. Kapur S., VanderSpek S.C., Brownlee B.A., and Nobrega J.N. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J. Pharmacol. Exp. Ther. 305 (2003) 625-631
15. Karp N.A., Griffin J.L., and Lilley K.S. Application of partial least squares discriminant analysis to two-dimensional difference gel studies in expression proteomics. Proteomics 5 (2005) 81-90
16. Karry R., Klein E., and Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol. Psychiatry 55 (2004) 676-684
17. La Y., Wan C., Zhu H., Yang Y., Chen Y., Pan Y., Ji B., Feng G., and He L. Hippocampus protein profiling reveals aberration of malate dehydrogenase in chlorpromazine/clozapine treated rats. Neurosci. Lett. 408 (2006) 29-34
18. Maniwa J., Izumi S., Isobe N., and Terada T. Studies on substantially increased proteins in follicular fluid of bovine ovarian follicular cysts using 2-D PAGE and MALDI-TOF MS. Reprod. Biol. Endocrinol. 3 (2005) 23
19. Marengo E., Robotti E., Bobba M., Milli A., Campostrini N., Righetti S.C., Cecconi D., and Righetti P.G. Application of partial least squares discriminant analysis and variable selection procedures: a 2D-PAGE proteomic study. Anal. Bioanal. Chem. 390 (2008) 1327-1342
20. Martins-de-Souza D., Gattaz W.F., Schmitt A., Maccarrone G., Hunyadi-Gulyas E., Eberlin M.N., Souza G.H., Marangoni S., Novello J.C., Turck C.W., and Dias-Neto E. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J. Psychiatr. Res. (2008)
21. Maurer I., and Moller H.J. Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol. Cell Biochem. 174 (1997) 255-259
22. Millar J.K., James R., Christie S., and Porteous D.J. Disrupted in schizophrenia 1 (DISC1): subcellular targeting and induction of ring mitochondria. Mol. Cell. Neurosci. 30 (2005) 477-484
23. Pastorelli R., Carpi D., Campagna R., Airoldi L., Pohjanvirta R., Viluksela M., Hakansson H., Boutros P.C., Moffat I.D., Okey A.B., and Fanelli R. Differential expression profiling of the hepatic proteome in a rat model of dioxin resistance: correlation with genomic and transcriptomic analyses. Mol. Cell. Proteomics 5 (2006) 882-894
24. Prince J.A., Blennow K., Gottfries C.G., Karlsson I., and Oreland L. Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 21 (1999) 372-379
25. Sgaragli G.P., Valoti M., Palmi M., Frosini M., Giovannini M.G., Bianchi L., and Della C.L. Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds. J. Pharm. Pharmacol. 47 (1995) 782-790
26. Snyder E.M., and Murphy M.R. Schizophrenia therapy: beyond atypical antipsychotics. Nat. Rev. Drug Discov. 7 (2008) 471-472
27. Spencer K.M., and McCarley R.W. Neuropsychiatric abnormalities: a new vista from studies on fundamental properties of neural communication. Psychiatric. Times 25 (2006)
28. Tian L., Zhang L., Zhang J., Song Y., and Guo Y. Differential proteomic analysis of soluble extracellular proteins reveals the cysteine protease and cystatin involved in suspension-cultured cell proliferation in rice. Biochim. Biophys. Acta 1794 (2009) 459-467
29. Vawter M.P., Thatcher L., Usen N., Hyde T.M., Kleinman J.E., and Freed W.J. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol. Psychiatry 7 (2002) 571-578
30. Whatley S.A., Curti D., Das G.F., Ferrier I.N., Jones S., Taylor C., and Marchbanks R.M. Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients. Mol. Psychiatry 3 (1998) 227-237
31. Zink M., Schmitt A., May B., Muller B., Demirakca T., Braus D.F., and Henn F.A. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression. Schizophr. Res. 66 (2004) 151-157